Xeljanz Xr

Tofacitinib Citrate

6.8 High risk

Xeljanz Xr & Drug ineffective

7.1%

of users reported Drug ineffective

70.3%

also reported Severe reaction

77.3%

are women

Most common medical consequences

Severe reaction
70.3%
Hospitalization
24.6%
Life-threatening condition
2.5%
Death
2.1%
Medical Intervention
0.4%

Have you experienced any negative side effects from this medication?

Xeljanz Xr: general information

Most common side effects (590)

Most commonly affected ages

10 - 19 years
0.3%
20 - 29 years
1.8%
30 - 39 years
4.8%
40 - 49 years
12.0%
50 - 59 years
27.7%
60 - 69 years
31.6%
70 - 79 years
17.2%
80 - 89 years
4.3%
90 - 99 years
0.3%